Summit Therapeutics Inc - ESG Rating & Company Profile powered by AI
The Disclosure score covers 17 UN SDGs including: 'Gender Equality', 'Reduced Inequalities' and 'Life on Land'. The webpage is a zero-cost Sustainability report for Summit Therapeutics Inc. Other corporations in the rating industry group for Summit Therapeutics Inc are shownin the table.
Summit Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.4; made up of an environmental score of 2.0, social score of 6.4 and governance score of 4.8.
4.4
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 868 | Trevena Inc | 4.5 | High |
| 868 | Urogen Pharma Ltd | 4.5 | High |
| 910 | Summit Therapeutics Inc | 4.4 | High |
| 910 | CanBas Co Ltd | 4.4 | High |
| 910 | CNS Pharmaceuticals Inc | 4.4 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Summit Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Summit Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Summit Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Summit Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Summit Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Summit Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Summit Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Summit Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Summit Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Summit Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Summit Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Summit Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Summit Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Summit Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Summit Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Summit Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Summit Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Summit Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Summit Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Summit Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Summit Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Summit Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Summit Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Summit Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Summit Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Summit Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Summit Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Summit Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Summit Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Summit Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Summit Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Summit Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Summit Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Summit Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Summit Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Summit Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Summit Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States, Latin America, and Europe. It conducts clinical programs focusing on the Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also develops DDS-01 series to treat infection caused by the bacteria Neisseria gonorrhoeae through Discuva platform; and DDS-04 series to treat Enterobacteriaceae. The company was founded in 2003 and is based in Cambridge, Massachusetts.